External traditional Chinese medicine for treating tuberculous pleurisy with introduction of magnetic heat

Abstract

The invention relates to an external traditional Chinese medicine for treating tuberculous pleurisy with introduction of magnetic heat and belongs to an external traditional Chinese medicine. The external traditional Chinese medicine is prepared from the following crude drugs in parts by weight: 50-100 parts of radix aconite, 50-100 parts of radix aconiti kusnezoffii, 20-30 parts of asarum, 50-80 parts of rhizoma alismatis, 50-100 parts of cassia twig, 50-100 parts of ligusticum wallichii, 30-60 parts of pseudo-ginseng, 30-50 parts of scorpio, 20-30 parts of safflower, 20-30 parts of mirabilite and 15-30 parts of semen strychni. Compared with the prior art, the external traditional Chinese medicine has the advantages of no toxic or side effect, good and rapid treating effect, low cost, convenient administration and the like.

Description

technical field [0001] The invention relates to a traditional Chinese medicine, in particular to an external Chinese medicine for treating tuberculous pleurisy by magnetothermal introduction. Background technique [0002] Tuberculous pleurisy, also known as tuberculous pleurisy, is a stubborn disease that is difficult to cure at present. The disease can cause chest tightness and pain in mild cases, and can cause chest deformation in severe cases. Moreover, it may cause delay or recurrence of tuberculosis At present, the clinical treatment of tuberculous pleural hypertrophy mostly adopts systemic therapy, drug therapy and surgical treatment; systemic therapy is mainly based on respiratory function exercise, increasing nutrition and strengthening physical fitness; Mainly and supplemented with Chuanqing and other drugs for promoting blood circulation and removing blood stasis; surgical treatment includes open thoracotomy and thoracoscopic pleurectomy; the above-mentioned treatm...

AI Technical Summary

Problems solved by technology

[0002] Tuberculous pleurisy, also known as tuberculous pleurisy, is a persistent disease that is difficult to cure at present. The disease can cause chest tightness and pain in mild cases, and can cause chest deformation in severe cases. Moreover, it may cause delay or recurrence of tuberculosis At present, the clinical treatment of tuberculous pleural hypertrophy mostly adopts systemic therapy, drug therapy and surgical treatment; systemic therapy is mainly based on respiratory function exercise, increasing nutrition and strengthening physical fitness; Mainly and supplemented with Chuanqing and other drugs for promoting blood circulation and removing blood stasis; surgical treatment includes thoracotomy and thoracoscopic pleurectomy; the above-mentioned treatment methods have certain curative effects on pleural hypertrophy caused by tuberculous pleurisy, but It has the disadvantages of large side effects, large trauma, and high cost, which brings great physical and mental harm to patients.